Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats

被引:47
|
作者
Deguchi, T
Kouno, Y
Terasaki, T
Takadate, A
Otagiri, M [1 ]
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan
[2] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Mol Biopharm & Genet, Aoba Ku, Sendai, Miyagi 9808578, Japan
[3] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808578, Japan
[4] Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Saitama 3320012, Japan
[5] Daiichi Coll Pharmaceut Sci, Minami Ku, Fukuoka 8150037, Japan
关键词
chronic renal failure; kidney uptake index; nephrotoxicity; organic anion transporters; uremic toxins;
D O I
10.1007/s11095-005-2486-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Evidence suggests that uremic toxins such as hippurate ( HA), indoleacetate (IA), indoxyl sulfate ( IS), and 3-carboxy-4-methyl-5-propyl-2-furanpropionate ( CMPF) promote the progression of renal failure by damaging tubular cells via rat organic anion transporter 1 (rOat1) and rOat3 on the basolateral membrane of the proximal tubules. The purpose of the current study is to evaluate the in vivo transport mechanism responsible for their renal uptake. Methods. We investigated the uremic toxins transport mechanism using the abdominal aorta injection technique [i. e., kidney uptake index (KUI) method], assuming minimal mixing of the bolus with serum protein from circulating serum. Results. Maximum mixing was estimated to be 5.8% of rat serum by measuring estrone sulfate extraction after addition of 0 - 90% rat serum to the arterial injection solution. Saturable renal uptake of p-aminohippurate (PAH, K-m = 408 mu M) and benzylpenicillin (PCG, K-m = 346 mu M) was observed, respectively. The uptake of PAH and PCG was inhibited in a dose-dependent manner by unlabeled PCG (IC50 = 47.3 mM) and PAH (IC50 = 512 mu M), respectively, suggesting that different transporters are responsible for their uptake. A number of uremic toxins inhibited the renal uptake of PAH and PCG. Excess PAH, which could inhibit rOat1 and rOat3, completely inhibited the saturable uptake of IA, IS, and CMPF by the kidney, and by 85% for HA uptake. PCG inhibited the total saturable uptake of HA, IA, IS, and CMPF by 10%, 10%, 45%, and 65%, respectively, at the concentration selective for rOat3. Conclusions. rOat1 could be the primary mediator of the renal uptake of HA and IA, accounting for approximately 75% and 90% of their transport, respectively. rOat1 and rOat3 contributed equally to the renal uptake of IS. rOat3 could account for about 65% of the uptake of CMPF under in vivo physiologic conditions. These results suggest that rOat1 and rOat3 play an important role in the renal uptake of uremic toxins and the induction of their nephrotoxicity.
引用
收藏
页码:619 / 627
页数:9
相关论文
共 29 条
  • [21] Reduced Renal Clearance of Cefotaxime in Asians with a Low-Frequency Polymorphism of OAT3 (SLC22A8)
    Yee, Sook Wah
    Anh Nguyet Nguyen
    Brown, Chaline
    Savic, Radojka M.
    Zhang, Youcai
    Castro, Richard A.
    Cropp, Cheryl D.
    Choi, Ji Ha
    Singh, Diment
    Tahara, Harunobu
    Stocker, Sophie L.
    Huang, Yong
    Brett, Claire M.
    Giacomini, Kathleen M.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (09) : 3451 - 3457
  • [22] Impaired renal organic anion transport 1 (SLC22A6) and its regulation following acute myocardial infarction and reperfusion injury in rats
    Sirijariyawat, Kungsadal
    Ontawong, Atcharaporn
    Palee, Siripong
    Thummasorn, Savitree
    Maneechote, Chayodom
    Boonphanga, Oranit
    Chatsudthipong, Varanuj
    Chattipakorn, Nipon
    Srimaroeng, Chutima
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (09): : 2342 - 2355
  • [23] Pharmacokinetic Significance of Renal OAT3 (SLC22A8) for Anionic Drug Elimination in Patients with Mesangial Proliferative Glomerulonephritis
    Yuji Sakurai
    Hideyuki Motohashi
    Ken Ogasawara
    Tomohiro Terada
    Satohiro Masuda
    Toshiya Katsura
    Noriko Mori
    Motokazu Matsuura
    Toshio Doi
    Atsushi Fukatsu
    Ken-ichi Inui
    Pharmaceutical Research, 2005, 22 : 2016 - 2022
  • [24] Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis
    Sakurai, Y
    Motohashi, H
    Ogasawara, K
    Terada, T
    Masuda, S
    Katsura, T
    Mori, N
    Matsuura, M
    Doi, T
    Fukatsu, A
    Inui, K
    PHARMACEUTICAL RESEARCH, 2005, 22 (12) : 2016 - 2022
  • [25] Regulation of Renal Organic Anion Transporter 3 (SLC22A8) Expression and Function by the Integrity of Lipid Raft Domains and their Associated Cytoskeleton
    Srimaroeng, Chutima
    Cecile, Jennifer Perry
    Walden, Ramsey
    Pritchard, John B.
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 31 (4-5) : 565 - 578
  • [26] Preclinical and Clinical Evidence for the Collaborative Transport and Renal Secretion of an Oxazolidinone Antibiotic by Organic Anion Transporter 3 (OAT3/SLC22A8) and Multidrug and Toxin Extrusion Protein 1 (MATE1/SLC47A1)
    Lai, Yurong
    Sampson, Kathleen E.
    Balogh, Larissa M.
    Brayman, Timothy G.
    Cox, Steven R.
    Adams, Wade J.
    Kumar, Vikas
    Stevens, Jeffrey C.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (03): : 936 - 944
  • [27] 6β-Hydroxycortisol Is an Endogenous Probe for Evaluation of Drug-Drug Interactions Involving a Multispecific Renal Organic Anion Transporter, OAT3/SLC22A8, in Healthy Subjects
    Imamura, Yuichiro
    Tsuruya, Yuri
    Damme, Katja
    Heer, Dominik
    Kumagai, Yuji
    Maeda, Kazuya
    Murayama, Nobuyuki
    Okudaira, Noriko
    Kurihara, Atsushi
    Izumi, Takashi
    Sugiyama, Yuichi
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (04) : 685 - 694
  • [28] Rat and mouse differences in gender-predominant expression of organic anion transporter (OAT1-3; SLC22A6-8) mRNA levels
    Buist, SCN
    Klaassen, CD
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (06) : 620 - 625
  • [29] Limited Brain Distribution of [3R,4R,5S]-4-Acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate Phosphate (Ro 64-0802), a Pharmacologically Active Form of Oseltamivir, by Active Efflux across the Blood-Brain Barrier Mediated by Organic Anion Transporter 3 (Oat3/Slc22a8) and Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4)
    Ose, Atsushi
    Ito, Mototsugu
    Kusuhara, Hiroyuki
    Yamatsugu, Kenzo
    Kanai, Motomu
    Shibasaki, Masakatsu
    Hosokawa, Masakiyo
    Schuetz, John D.
    Sugiyama, Yuichi
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (02) : 315 - 321